Data gap threatens to complicate Johnson & Johnson vaccine pause
Erin Banco et al., Politico
The current investigation could intensify concerns by state officials that the public will lose overall confidence in Covid-19 vaccines.
‘We Were Flying Blind’: A Dr.’s Account of a Woman’s J.&J. Vaccine-Related Blood Clot Case
Denise Grady, The New York Times
The disorder is rare, but so severe that the vaccine is on hold while experts weigh the risks and alert doctors and patients about symptoms and treatment.
J&J Covid-19 Vaccine Pause Driven by Risk of Mistreating Blood Clots
Thomas M. Burton and Betsy McKay, The Wall Street Journal
U.S. health authorities came close to simply warning about a blood-clotting risk from Johnson & Johnson’s Covid-19 vaccine, but decided to recommend pausing use out of concern doctors would improperly treat the condition, people familiar with the matter said.
Why the Vaccine Safety Numbers Are Still Fuzzy
Margot Sanger-Katz and Alicia Parlapiano, The New York Times
Putting a risk in context: The rate of blood clots is extremely low, but the pause in the Johnson & Johnson vaccine could reveal more cases.
‘Ripe for fraud’: Coronavirus vaccination cards support burgeoning scams
Dan Diamond, The Washington Post
At least 129.5 million Americans have gotten at least one or both doses of a coronavirus vaccine and have received a free proof-of-vaccination card with the logo of the Centers for Disease Control and Prevention, as officials push to inoculate the nation.
N.I.H. awards $33 million to fund research on coronavirus testing in schools.
Emily Anthes, The New York Times
The National Institutes of Health is investing $33 million in research projects run by institutions around the country that could help officials safely reopen schools serving vulnerable students and under-resourced rural, urban and Native American communities.
Covid-19 ‘Challenge Trial’ Will Purposely Reinfect Adults
Jenny Strasburg, The Wall Street Journal
University of Oxford scientists plan to reinfect dozens of adult volunteers with the coronavirus in the second U.K. clinical trial to study deliberate Covid-19 infection in quarantine—this time among people who have already recovered from the virus.
Covid Survivors May Require Just One Shot of a Two-Dose Vaccine
Carey Goldberg, Bloomberg
The issue of giving only a single dose to people who have had Covid has become all the more urgent since safety concerns have been raised about Johnson & Johnson’s and AstraZeneca’s vaccines.
The Covid-19 Plasma Boom Is Over. What Did We Learn From It?
Katie Thomas and Noah Weiland, The New York Times
The U.S. government invested $800 million in plasma when the country was desperate for Covid-19 treatments. A year later, the program has fizzled.
How Safe Are You From Covid When You Fly?
Mika Gröndahl et al., The New York Times
How air flows in planes is not the only part of the safety equation, according to infectious-disease experts: The potential for exposure may be just as high, if not higher, when people are in the terminal, sitting in airport restaurants and bars or going through the security line.
‘They Just Feel That They’ve Been Violated’
Bryce Covert, The Atlantic
The COVID-19 crisis is nearing its end. But the nurses and home health aides who saw us through it may never recover.